Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis

Advances in the field of cancer immunology, including studies on tumor-infiltrating CD8(+) cytotoxic T lymphocytes (CTLs), have led to new immunotherapeutics with proven efficacy against late-stage cancers. However, the antitumor potential of the immune system in targeting early-stage cancers remain...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Invest
Main Authors: Demehri, Shadmehr, Cunningham, Trevor J., Manivasagam, Sindhu, Ngo, Kenneth H., Moradi Tuchayi, Sara, Reddy, Rasika, Meyers, Melissa A., DeNardo, David G., Yokoyama, Wayne M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811115/
https://ncbi.nlm.nih.gov/pubmed/26927668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI83724
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki